FDA’s Division of Dietary Supplement Programs is now its own Office within the agency’s Center for Food Safety and Applied Nutrition (CFSAN).
Photo © iStockphoto.com/ajt
FDA’s Division of Dietary Supplement Programs is now its own Office within the agency’s Center for Food Safety and Applied Nutrition (CFSAN). Dietary supplement industry associations praised the division’s elevated status to an Office, stating that this new position will not only increase the profile of the dietary supplement industry within the federal government but also help secure and enhance enforcement resources to catch those who illegally sell products as dietary supplements.
Five leading trade associations welcomed the news: the American Herbal Products Association, the Consumer Healthcare Products Association, the Council for Responsible Nutrition, the Natural Products Association, and the United Natural Products Alliance.
The Office of Dietary Supplements joins other Offices within CFSAN, including the Office of Cosmetics, the Office of Food Additives, and the Office of Food Safety. Read more about CFSAN’s organization here.
“This is a long overdue step towards elevating the dietary supplement division within FDA so that it can exercise all the authorities it has to regulate this important industry,” said Dan Fabricant, PhD, Executive Director and CEO of the Natural Products Association. “We strongly support this decision and will continue to work with FDA and other regulatory officials to deliver quality products for the millions of people in the U.S. and around the world.”
Jennifer Grebow
Editor-in-Chief
Nutritional Outlook magazine
jennifer.grebow@ubm.com
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.